• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成瘾与抑郁:育龄期女性未满足的治疗需求。

Addiction and Depression: Unmet Treatment Needs Among Reproductive Age Women.

机构信息

Department of Obstetrics and Gynecology & Institute for Drug and Alcohol Studies, Virginia Commonwealth University School of Medicine, 1250 E Marshall St., Box #980034, Richmond, VA, 23298, USA.

Virginia Department of Medicaid Assistance Services, 801 E Marshall St, Richmond, VA, 23219, USA.

出版信息

Matern Child Health J. 2020 May;24(5):660-667. doi: 10.1007/s10995-020-02904-8.

DOI:10.1007/s10995-020-02904-8
PMID:32185570
Abstract

OBJECTIVES

To describe the current unmet major depression and substance use disorder (SUD) treatment needs among reproductive age women METHODS: Data from the 2007 to 2014 National Survey on Drug Use and Health (NSDUH) were analyzed to determine proportions of women ages 18 to 44 years with unmet treatment need for depression and SUD. Logistic regression determined factors associated with receiving past year SUD and major depression treatment among those in need.

RESULTS

Only 9.2% of women with past year SUD treatment need received treatment (95% CI 8.3-10.1%) compared to 60.7% for those in need of depression treatment (95% CI 59.5-62.0%). Over time, treatment receipt for depression increased significantly (OR 1.4, 95% CI 1.15-1.67) but not for substance use disorders (OR 1.4, 95% CI 0.69-1.45). Neither pregnant nor parenting women were more likely to receive treatment for SUD or depression. Young and racial/ethnically minority women were less likely to receive needed behavioral health treatment for either condition.

CONCLUSIONS

Depression and SUD treatment need are common among women. However, treatment receipt differs between these behavioral health conditions.

摘要

目的

描述生殖年龄女性中目前未满足的重度抑郁症和物质使用障碍(SUD)治疗需求。

方法

对 2007 年至 2014 年全国药物使用和健康调查(NSDUH)的数据进行分析,以确定 18 至 44 岁女性中未满足重度抑郁症和 SUD 治疗需求的比例。逻辑回归确定了有需要的人群中过去一年 SUD 和重度抑郁症治疗的相关因素。

结果

仅有 9.2%有过去一年 SUD 治疗需求的女性接受了治疗(95%CI 8.3-10.1%),而有重度抑郁症治疗需求的女性中,接受治疗的比例为 60.7%(95%CI 59.5-62.0%)。随着时间的推移,重度抑郁症的治疗接受率显著增加(OR 1.4,95%CI 1.15-1.67),但 SUD 的治疗接受率没有增加(OR 1.4,95%CI 0.69-1.45)。怀孕或有子女的女性都不太可能接受 SUD 或重度抑郁症的治疗。年轻和种族/族裔少数群体的女性接受这两种疾病所需的行为健康治疗的可能性较小。

结论

重度抑郁症和 SUD 的治疗需求在女性中很常见。然而,这两种行为健康状况的治疗接受率存在差异。

相似文献

1
Addiction and Depression: Unmet Treatment Needs Among Reproductive Age Women.成瘾与抑郁:育龄期女性未满足的治疗需求。
Matern Child Health J. 2020 May;24(5):660-667. doi: 10.1007/s10995-020-02904-8.
2
Unmet substance use disorder treatment need among reproductive age women.生育年龄妇女未满足的物质使用障碍治疗需求。
Drug Alcohol Depend. 2020 Jan 1;206:107679. doi: 10.1016/j.drugalcdep.2019.107679. Epub 2019 Oct 28.
3
Depression care among depressed adults with and without comorbid substance use disorders in the United States.美国患有和未患有合并物质使用障碍的抑郁症成年人的抑郁症护理情况。
Depress Anxiety. 2017 Mar;34(3):291-300. doi: 10.1002/da.22592. Epub 2017 Feb 2.
4
Depression care among adults with co-occurring major depressive episodes and substance use disorders in the United States.美国同时患有重度抑郁发作和物质使用障碍的成年人的抑郁护理情况。
J Psychiatr Res. 2017 Aug;91:47-56. doi: 10.1016/j.jpsychires.2017.02.026. Epub 2017 Mar 1.
5
Trends and Disparities in Treatment for Co-occurring Major Depression and Substance Use Disorders Among US Adolescents From 2011 to 2019.2011 年至 2019 年美国青少年共病重度抑郁症和物质使用障碍的治疗趋势和差异。
JAMA Netw Open. 2021 Oct 1;4(10):e2130280. doi: 10.1001/jamanetworkopen.2021.30280.
6
Racial/ethnic differences in mental health treatment among a national sample of pregnant women with mental health and/or substance use disorders in the United States.美国有心理健康和/或药物使用障碍的孕妇全国样本中,心理健康治疗的种族/民族差异。
J Psychosom Res. 2019 Jun;121:74-80. doi: 10.1016/j.jpsychores.2019.03.015. Epub 2019 Mar 16.
7
Need for and Receipt of Substance Use Disorder Treatment Among Adults, by Gender, in the United States.美国成年人性别差异与物质使用障碍治疗需求和治疗接受情况。
Public Health Rep. 2022 Sep-Oct;137(5):955-963. doi: 10.1177/00333549211041554. Epub 2021 Sep 21.
8
Prevalence and correlates of major depressive episode in pregnant and postpartum women in the United States.美国孕妇和产后女性重性抑郁发作的患病率及相关因素。
J Affect Disord. 2011 Dec;135(1-3):128-38. doi: 10.1016/j.jad.2011.07.004. Epub 2011 Jul 29.
9
Gender differences in substance abuse treatment and barriers to care among persons with substance use disorders with and without comorbid major depression.物质使用障碍患者中合并与不合并重性抑郁障碍者在物质滥用治疗及治疗障碍方面的性别差异。
J Addict Med. 2013 Sep-Oct;7(5):325-34. doi: 10.1097/ADM.0b013e31829b7afe.
10
Receiving addiction treatment in the US: Do patient demographics, drug of choice, or substance use disorder severity matter?在美国接受成瘾治疗:患者人口统计学特征、选择的药物或物质使用障碍严重程度是否重要?
Int J Drug Policy. 2020 Jan;75:102583. doi: 10.1016/j.drugpo.2019.10.009. Epub 2019 Nov 15.

引用本文的文献

1
Global burden of diseases attributed to mental and substance use disorders in reproductive-age women: an ecological analysis for the Global Burden of Disease Study 2021.育龄妇女中归因于精神和物质使用障碍的全球疾病负担:2021年全球疾病负担研究的一项生态分析
Mol Psychiatry. 2025 Sep 8. doi: 10.1038/s41380-025-03216-5.
2
Perceived Unmet Need for Care and Barriers to Care Among Individuals with Mental Health Issues: A Meta-analysis.心理健康问题患者对未满足的护理需求及护理障碍的认知:一项荟萃分析。
Adm Policy Ment Health. 2025 May 2. doi: 10.1007/s10488-025-01446-x.
3
Pregnancy-specific alcohol policies and admissions to substance use disorder treatment for pregnant people in the USA.

本文引用的文献

1
Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.与产妇在分娩后一年内阿片类药物过量相关的母婴特征。
Addiction. 2020 Feb;115(2):291-301. doi: 10.1111/add.14825. Epub 2019 Nov 13.
2
Association Between Severe Maternal Morbidity and Psychiatric Illness Within 1 Year of Hospital Discharge After Delivery.分娩后住院出院后 1 年内严重产妇发病率与精神疾病之间的关联。
Obstet Gynecol. 2019 Oct;134(4):695-707. doi: 10.1097/AOG.0000000000003434.
3
Pregnancy-Associated Death in Utah: Contribution of Drug-Induced Deaths.
美国针对孕妇的特定酒精政策与物质使用障碍治疗入院情况。
Alcohol Alcohol. 2023 Nov 11;58(6):645-652. doi: 10.1093/alcalc/agad056.
4
Prevalence of cannabis use disorder among pregnant people who test positive for cannabis at time of delivery.分娩时大麻检测呈阳性的孕妇中大麻使用障碍的患病率。
AJOG Glob Rep. 2022 Sep 1;2(4):100095. doi: 10.1016/j.xagr.2022.100095. eCollection 2022 Nov.
5
Miscarriage Risk Factors for Pregnant Women: A Cohort Study in Eastern Algeria's Population.孕妇流产风险因素:阿尔及利亚东部人群的队列研究
J Obstet Gynaecol India. 2022 Aug;72(Suppl 1):109-120. doi: 10.1007/s13224-021-01564-0. Epub 2021 Oct 6.
6
Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors.新生儿阿片戒断综合征的严重程度与产前暴露于 5-羟色胺再摄取抑制剂有关。
Pediatr Res. 2022 Mar;91(4):867-873. doi: 10.1038/s41390-021-01756-4. Epub 2021 Sep 29.
7
Patient and provider knowledge of and attitudes toward medical conditions and medication during pregnancy.患者和提供者对妊娠期间医疗状况和药物的了解和态度。
Addict Sci Clin Pract. 2021 Mar 29;16(1):22. doi: 10.1186/s13722-021-00228-8.
8
The MATernaL and Infant NetworK to Understand Outcomes Associated with Treatment of Opioid Use Disorder During Pregnancy (MAT-LINK): Surveillance Opportunity.母婴网络以了解与孕期阿片类药物使用障碍治疗相关的结局(MAT-LINK):监测机会。
J Womens Health (Larchmt). 2020 Dec;29(12):1491-1499. doi: 10.1089/jwh.2020.8848. Epub 2020 Nov 23.
犹他州妊娠相关死亡:药物性死亡的贡献。
Obstet Gynecol. 2019 Jun;133(6):1131-1140. doi: 10.1097/AOG.0000000000003279.
4
Review: Sex-Based Differences in Treatment Outcomes for Persons With Opioid Use Disorder.综述:阿片类药物使用障碍患者治疗结局的性别差异。
Am J Addict. 2019 Jul;28(4):246-261. doi: 10.1111/ajad.12921. Epub 2019 May 26.
5
Medication-Assisted Treatment Use Among Pregnant Women With Opioid Use Disorder.药物辅助治疗在患有阿片类药物使用障碍的孕妇中的应用。
Obstet Gynecol. 2019 May;133(5):943-951. doi: 10.1097/AOG.0000000000003231.
6
Accuracy of Three Screening Tools for Prenatal Substance Use.三种产前物质使用筛查工具的准确性。
Obstet Gynecol. 2019 May;133(5):952-961. doi: 10.1097/AOG.0000000000003230.
7
Interventions to Prevent Perinatal Depression: US Preventive Services Task Force Recommendation Statement.预防围产期抑郁的干预措施:美国预防服务工作组推荐声明。
JAMA. 2019 Feb 12;321(6):580-587. doi: 10.1001/jama.2019.0007.
8
Levels and predictors of participation in integrated treatment programs for pregnant and parenting women with problematic substance use.患有物质使用问题的孕妇和哺乳期妇女参与综合治疗项目的水平和预测因素。
BMC Public Health. 2019 Feb 6;19(1):154. doi: 10.1186/s12889-019-6455-4.
9
Trajectories of maternal depressive and anxiety symptoms from pregnancy to five years postpartum and their prenatal predictors.孕产妇从孕期到产后五年期间抑郁和焦虑症状的轨迹及其产前预测因素。
BMC Pregnancy Childbirth. 2019 Jan 14;19(1):26. doi: 10.1186/s12884-019-2177-y.
10
Trends in pregnancy-associated mortality involving opioids in the United States, 2007-2016.2007 - 2016年美国与阿片类药物相关的妊娠相关死亡率趋势
Am J Obstet Gynecol. 2019 Jan;220(1):115-116. doi: 10.1016/j.ajog.2018.09.028. Epub 2018 Sep 28.